Skip to main content
Fig. 3 | BMC Rheumatology

Fig. 3

From: Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity

Fig. 3

Healthcare resource utilization in past 12 months by disease activity. Patients were considered to have low disease activity if they had a SLEDAI score of ≤ 4 and were receiving a glucocorticoid dose of ≤ 7.5 mg/day; patients were considered to have active disease if they had a SLEDAI score of > 4 or were receiving a glucocorticoid at a dose of > 7.5 mg/day. CI, confidence interval; HCP, healthcare professional; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us